If you have been diagnosed with non-melanoma skin cancer, learn more about a gentler way to treat skin cancer.
See the growing clinical evidence supporting the use of Image-Guided Superficial Radiation Therapy (Image-Guided SRT) as a first-line treatment option for patients with NMSC.
Yu L, et al. Oncol Ther. 2021;9(1):153-166.
99.3% local control rates with an industry-proven, 20-faction protocol—IG-SRT is safe and tolerable and should be considered a first-line option for NMSC
Cure rates observed in this initial period of follow-up are similar, and potentially superior with further follow-up, to traditional SRT and surgical options.
Yu L, et al. Discov Oncol. 2022;13(1):129.
Local control rates for the 2 US-SRT studies were statistically superior to the 4 traditional therapies individually and collectively. When stratified by histology, statistically superior outcomes for US-SRT were observed in all subtypes
US-SRT is statistically superior to non–image-guided radiotherapies for NMSC treatment. This modality may represent the future standard of non-surgical treatment for early-stage NMSC.
Yu L, et all. BMC Cancer. 2023;23(1):98.
Local control rates with US-SRT were statistically superior to those found in studies using non–image-guided radiation therapy, individually and comparatively and across histological subtypes, with P-values ranging from P<.0001 to P=.0438
Image guidance with high resolution dermal ultrasound in the form of US-SRT is shown to confer a statistically significant advantage in lesion local control over non–image-guided forms of SRT or XRT in all subtypes of cutaneous epithelial NMSC and should be considered the preferred standard of non-surgical treatment for early-stage cutaneous BCC, SCC, and SCCIS.
Tran A, et al. J Cancer Res Clin Oncol. 2023.
99.7% of patients achieved absolute lesion local control after an average of 7.5 weeks of treatment, 99.6% of patients achieved stable control with >12 months follow-up, and 95% of lesions had a RTOG score of 1 or 2
IG-SRT has a high safety profile, can achieve superior cosmesis and should be considered first-line for treating early-stage NMSC tumors as cure rates have been shown to be effective in all NMSC on early follow-up…making it a safe, and potentially cost-effective option for NMSC treatment compared to surgery.
Tran A, Yu L. J Dermaol Skin Sci. 2022;4(4):6-8.
The use of modern superficial radiation therapy might address disparities in dermatologic care.
Interested in making Image-Guided SRT a treatment option at your practice? Contact us to discuss all the ways SkinCure Oncology can help.